Abstract
Objectives
Up to 20 % of incidentally found testicular lesions are benign Leydig cell tumours (LCTs). This study evaluates the role of contrast-enhanced magnetic resonance imaging (MRI) in the identification of LCTs in a large prospective cohort study.
Materials and methods
We enrolled 44 consecutive patients with at least one solid non-palpable testicular lesion who underwent scrotal MRI. Margins of the lesions, signal intensity and pattern of wash-in and wash-out were analysed by two radiologists. The frequency distribution of malignant and benign MRI features in the different groups was compared by using the chi-squared or Fisher’s exact test. Sensitivity, specificity, positive and negative predictive value, and diagnostic accuracy were calculated.
Results
The sensitivity of scrotal MRI to diagnose LCTs was 89.47 % with 95.65 % specificity; sensitivity for malignant lesions was 95.65 % with 80.95 % specificity. A markedly hypointense signal on T2-WI, rapid and marked wash-in followed by a prolonged washout were distinctive features significantly associated with LCTs. Malignant lesions were significantly associated with blurred margins, weak hypointense signal on T2-WI ,and weak and progressive wash-in. The overall diagnostic accuracy was 93 %.
Conclusions
LCTs have distinctive contrast-enhanced MRI features that allow the differential diagnosis of incidental testicular lesions.
Key Points
• MRI is able to characterize testicular lesions suggesting a specific diagnosis.
• Rapid and marked wash-in is a common feature of Leydig cell tumours.
• Markedly hypointense T2-WI signal is significantly correlated with benign lesions.
• Blurred margins and weak hypointense T2-WI signal are correlated with malignant tumours.
• Weak and progressive wash-in features are present in 85 % of seminomatous lesions.
Similar content being viewed by others
References
La Vecchia C, Bosetti C, Lucchini F et al (2010) Cancer Mortality in Europe, 2000-2004, and an overview of trends since 1995. Ann Oncol 21(6):1323–1360
Isidori A, Pozza C, Gianfrilli et al (2014) Differential diagnosis of non-palpable testicular lesions: qualitative and quantitative contrast enhanced ultrasound of benign and malignant testicular tumours. Radiology 273(2):606–618
Carmignani L, Colombo R, Gadda F et al (2007) Conservative surgical therapy for Leydig cell tumour. J Urol 178(2):507–511
Giannarini G, Dieckmann KP, Abers P et al (2010) Organ sparing surgery for adult testicular tumours: a systemaic review of the literature. Eur Urol 57(5):780–790
Dogra VS, Gottlieb RH, Oka M et al (2003) Sonography of the scrotum. Radiology 227(18–36):31
Sohaib SA, Koh DW, Husband JE (2008) The role of imaging in the diagnosis, staging and management of testicular cancer. AJR 191:387–395
Lock G, Schröder C, Schmidt C et al (2014) Contrast-Enhanced Ultrasound and Real-Time Elastography for the Diagnosis of Benign Leydig Cell Tumours of the Testis - A Single Center Report on 13 Cases. Ultraschall Med 35(6):534–539
Huang DY, Sidhu F (2012) Focal testicular lesions: colour Doppler ultrasound, contrast-enhanced ultrasound and tissue elastography as adjuvants to the diagnosis. Br J Radiol 85(1):41–53
Cantisani V, Olive M, Di Segni M et al (2012) Contrast-enhanced ultrasonographic (CEUS) and elastosonographic features of a case of testicular Leydig tumour. Ultraschall Med 33(5):407–409
Kim W, Rosen MA, Langer JE et al (2007) US-MR Imaging correlation in pathologic conditions of the scrotum. Radiographics 27(5):1239–1253
Watanabe Y, Dohke M, Ohkudo K et al (2000) Scrotal disorders: evaluation of testicular enhancement patterns at dynamic contrast-enhanced subtraction MR imaging. Radiology 217:219–227
Tsili AC, Argyropoulou MI, Astrakas LG et al (2013) Dynamic contrast-enhanced subtraction MRI for characterizing intratesticular mass lesions. AJR 200:578–585
Fleiss JL, Kingman A (1990) Statistical management of data in clinical research. Crit Rev Oral Biol Med 1:55–66
Isidori AM, Lenzi A (2008) Scrotal Ultrasound: Morphological and Functional Atlas. Editore Accademia Nazionale di Medicina 19:49
Schill W. B. et al. (2010) Andrologia clinica. Traduzione a cura di Lenzi A. ed Isidori A.M. Springer-Verlag Italia, p.183
Schmoll HJ et al (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15:1377–1399
Schwerk WB, Schwerk WN, Rodeck G (1987) Testicular tumours: prospective analysis of real-time US patterns and abdominal staging. Radiology 164:369–374
Rifkin MD, Kurtz AB, Pasto ME et al (1985) Diagnostic capabilities of highresolution scrotal ultrasonography: prospective evaluation. J Ultrasound Med 4:13–19
Benson CB, Doubilet PM, Richie JP (1989) Sonography of the male genital tract. AJR Am J Roentgenol 153:705–713
Lock G, Schmidt C, Helmich F et al (2011) Early experience with contrast-enhanced ultrasound in the diagnosis of testicular masses: a feasibility study. Urology 77(5):1049–1053
Shah A, Lung PF, Clarke JL et al (2010) Re: New ultrasound techniques for imaging of the indeterminate testicular lesion may avoid surgery completely. Clin Radiol 65:496–497
Muglia V, Tucci S, Elias J et al (2002) Magnetic resonance imaging of scrotal diseases: when it makes the difference. Urology 59:419–423
Cramer BM, Schlegel EA, Thueroff JW (1991) MR imaging in the differential diagnosis of scrotal and testicular disease. RadioGraphics 11:9–21
Adham WK, Raval BK, Uzquiano MC et al (2005) Best Cases from the AFIP: Bilateral Testicular Tumors: Seminoma and Mixed Germ Cell Tumor. Radiographics 25:835–839
Schultz-Lampel D, Bogaert G et al (1991) (1991) MRI for evaluation of scrotal pathology. Urol Res 19:289–292
Tsili AC, Tsampoulas C, Giannakopoulos X et al (2007) MRI in the histologic characterization of testicular neoplasms. AJR 189:1473
Algebally AM, Tantawy HI, Yousef RR (2014) Value of diffusion weighted magnetic resonance imaging in diagnosis and characterization of scrotal abnormalities. Egypt J Radiol Nucl Med 45(3):949–958
Tsili AC, Argyropoulou MI, Giannakis D et al (2012) Diffusion-weighted MR imaging of normal and abnormal scrotum: preliminary results. Asian J Androl 14(4):649–654
Samson M, Peale FV Jr, Frantz G et al (2004) Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis. J Clin Endocrinol Metab 89(8):4078–4088
Kilic N, Lauke H, Fiedler W et al (1999) Angiogenic switch and vascular stability in human Leydig cell tumours. Angiogenesis 3(3):231–240
Fernández GC, Tardáguila F, Rivas C et al (2004) Case report: MRI in the diagnosis of testicular Leydig cell tumour. Br J Radiol 77(918):521–524
Giannetta E, Gianfrilli D, Barbagallo F (2012) Subclinical male hypogonadism. Best Pract Res Clin Endocrinol Metab 26(4):539–550
Rosai J (2004) Rosai and Ackerman’s surgical pathology, 9th ed., vol. 1. Elsevier, Philadelphia, PA
Ulbright TM, Amin MB, Young RH (1997) Atlas of tumor pathology: tumors of the testis, adnexa, spermatic cord, and scrotum. 3rd ser, fasc 25. Armed Forces Institute of Pathology, Washington, pp 59–191
Acknowledgments
The scientific guarantor of this publication is Lucia Manganaro. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. One of the authors has significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Some study subjects or cohorts have been reported in a previous CEUS study by Isidori et al. (Radiol 273(2):606-18) conducted in parallel with our study.
Methodology: prospective, diagnostic study, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manganaro, L., Vinci, V., Pozza, C. et al. A prospective study on contrast-enhanced magnetic resonance imaging of testicular lesions: distinctive features of Leydig cell tumours. Eur Radiol 25, 3586–3595 (2015). https://doi.org/10.1007/s00330-015-3766-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-015-3766-4